Artelo Biosciences (ARTL) Institutional Ownership → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free ARTL Stock Alerts $1.32 -0.14 (-9.62%) (As of 04/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Artelo Biosciences (NASDAQ:ARTL)CurrentInstitutional OwnershipPercentage0.87%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.18K Get ARTL Insider Trade Alerts Want to know when executives and insiders are buying or selling Artelo Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARTL Institutional Buying and Selling by Quarter Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! Artelo Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2023Two Sigma Advisers LP27,262$63K0.0%-24.2%0.955% 11/15/2022Two Sigma Advisers LP35,062$121K0.0%N/A1.228% 11/15/2022Two Sigma Investments LP10,608$37K0.0%N/A0.371% 11/15/2022Vanguard Group Inc.71,038$245K0.0%-89.6%2.487% 5/13/2022Renaissance Technologies LLC182,619$82K0.0%+67.8%0.432% 5/13/2022Vanguard Group Inc.683,896$308K0.0%-23.2%1.617% 9/17/2021Virtu Financial LLC22,594$27K0.0%-85.3%0.092% 8/13/2021Renaissance Technologies LLC556,738$663K0.0%N/A2.273% 8/13/2021Vanguard Group Inc.862,172$1.03M0.0%+247.5%3.520% 8/12/2021Penserra Capital Management LLC28,427$27K0.0%N/A0.116% 8/11/2021Bank of New York Mellon Corp86,603$103K0.0%-15.4%0.354% 8/6/2021HighTower Advisors LLC62,000$74K0.0%N/A0.253% 5/19/2021Virtu Financial LLC153,769$251K0.0%N/A0.664% 5/18/2021Citadel Advisors LLC180,814$295K0.0%N/A0.781% 5/18/2021Jane Street Group LLC21,108$34K0.0%N/A0.091% 5/13/2021Kepos Capital LP200,000$326K0.0%-20.0%0.864% 5/13/2021Bank of New York Mellon Corp102,390$167K0.0%N/A0.442% 5/12/2021Geode Capital Management LLC141,273$230K0.0%+132.1%0.610% 5/12/2021UBS Group AG15,675$26K0.0%N/A0.068% 4/6/2021LVM Capital Management Ltd. MI20,000$33K0.0%N/A0.127% (Data available from 1/1/2016 forward) ARTL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARTL shares? During the previous two years, the following institutional investors and hedge funds held shares of Artelo Biosciences shares: Vanguard Group Inc. ($245K), Renaissance Technologies LLC ($82K), and Two Sigma Advisers LP ($63K), Two Sigma Investments LP ($37K).Learn more on ARTL's institutional investors. What percentage of Artelo Biosciences stock is owned by institutional investors? 0.87% of Artelo Biosciences stock is owned by institutional investors. Learn more on ARTL's institutional investor holdings. Which institutional investors have been buying Artelo Biosciences stock? The following institutional investors have purchased Artelo Biosciences stock in the last 24 months: Renaissance Technologies LLC ($73.82K), Two Sigma Advisers LP ($35.06K), and Two Sigma Investments LP ($10.61K). How much institutional buying is happening at Artelo Biosciences? Institutional investors have bought a total of 119,489 shares in the last 24 months. This purchase volume represents approximately $655.84K in transactions. Which Artelo Biosciences major shareholders have been selling company stock? The following institutional investors have sold Artelo Biosciences stock in the last 24 months: Vanguard Group Inc. ($819.89K), and Two Sigma Advisers LP ($8.70K). How much institutional selling is happening at Artelo Biosciences? Institutional investors have sold a total of 828,585 shares in the last 24 months. This volume of shares sold represents approximately $3.53M in transactions. Related Companies: Ensysce Biosciences Major Shareholders Kazia Therapeutics Major Shareholders Lipella Pharmaceuticals Major Shareholders Petros Pharmaceuticals Major Shareholders Genprex Major Shareholders PaxMedica Major Shareholders Processa Pharmaceuticals Major Shareholders ZyVersa Therapeutics Major Shareholders Soligenix Major Shareholders Tharimmune Major Shareholders This page (NASDAQ:ARTL) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsUrgent alert: open this for a huge profit potentialTimothy SykesBiden out June 13; Kamala won’t replace him?Paradigm PressOptions trading has suddenly become more reliable.Eagle PublishingA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.